Prognostic value of carcinoembryonic antigen (CEA) and CA 19-9 levels in patients with obstructive colorectal cancer treated with a self-expandable metallic stent and curative surgery
Surgery Today · 2025
DOI: 10.1007/s00595-024-02943-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgery Today, 2025. Verfasst von Ryuichiro Sato und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Gastroenterological Surgery, Sendai City Medical Center Sendai Open Hospital, 5-22-1 Tsurugaya, Miyagino-Ku, Sendai, 983-0824, Japan. …. Hauptthemen laut MEDLINE: Carcinoembryonic Antigen, CA-19-9 Antigen, Colorectal Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: The importance of tumor markers is well established; yet little is known about their prognostic value for patients with obstructive colorectal cancer (OCRC). We investigated the clinical significance of carcinoembryonic antigen (CEA) and CA 19-9 levels in patients with non-metastatic OCRC, who underwent insertion of a self-expandable metallic stent and curative surgery. METHODS: Clinical data on 91 patients with OCRC were analyzed retrospectively to evaluate the associations of preoperative serum values of tumor makers with short- and long-term outcomes. RESULTS: The 91 patients comprised 53 men and 38 women, with a median age of 71 years. Twelve patients had an elevated preoperative CA 19-9 level. Multivariate analyses revealed that an elevated CA 19-9 level was independently associated with poor disease-free survival (DFS) [hazard ratio (HR) = 4.57, 95% confidence interval (CI) 2.06-10.14, P 5 ng/ml had no prognostic value, whereas a CEA level > 10.8 ng/ml was significantly associated with worse DFS (P = 0.032). CONCLUSION: Measuring the CA 19-9 level concomitantly with the CEA level for patients with advanced CRC, including OCRC, may provide a valuable means to improve prognostication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Gastroenterological Surgery, Sendai City Medical Center Sendai Open Hospital, 5-22-1 Tsurugaya, Miyagino-Ku, Sendai, 983-0824, Japan. rsato-thk@umin.ac.jp.
- Department of Surgery, Miyagi Cancer Center, 47-1 Nodayama, Medeshima-Shiode, Natori, Miyagi, 981-1293, Japan. rsato-thk@umin.ac.jp.
- Departments of Gastroenterological Surgery, Sendai City Medical Center Sendai Open Hospital, 5-22-1 Tsurugaya, Miyagino-Ku, Sendai, 983-0824, Japan.
- Departments of Gastroenterology, Sendai City Medical Center Sendai Open Hospital, 5-22-1 Tsurugaya, Miyagino-Ku, Sendai, 983-0824, Japan.
Zitieren
APA
Sato, R., Oikawa, M., Kakita, T., Abe, T., Akazawa, N., Okano, H., Ito, K., & Tsuchiya, T. (2025). Prognostic value of carcinoembryonic antigen (CEA) and CA 19-9 levels in patients with obstructive colorectal cancer treated with a self-expandable metallic stent and curative surgery. Surgery Today. https://doi.org/10.1007/s00595-024-02943-6
Vancouver
Sato R, Oikawa M, Kakita T, Abe T, Akazawa N, Okano H, et al. Prognostic value of carcinoembryonic antigen (CEA) and CA 19-9 levels in patients with obstructive colorectal cancer treated with a self-expandable metallic stent and curative surgery. Surgery Today. 2025. doi:10.1007/s00595-024-02943-6
BibTeX
@article{Sato2025,
author = {Sato, Ryuichiro and Oikawa, Masaya and Kakita, Tetsuya and Abe, Tomoya and Akazawa, Naoya and Okano, Haruka and Ito, Kei and Tsuchiya, Takashi},
title = {Prognostic value of carcinoembryonic antigen (CEA) and CA 19-9 levels in patients with obstructive colorectal cancer treated with a self-expandable metallic stent and curative surgery},
journal = {Surgery Today},
year = {2025},
doi = {10.1007/s00595-024-02943-6}
}
EUVIMED